Summary Information:
INVO BioScience Inc. Common Stock
NASDAQ:INVO


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


INVO BioScience Inc. Common Stock
Exchange: NASDAQ
Symbol: INVO
SEC CIK: 0001417926
Phone: (978) 878-9505
5582 BROADCAST COURT
SARASOTA FL 34240

CEO:
Price when page updated: 1.864 Date: 2023-11-30
Company Website:
www.invobioscience.com

_Description: INVO Bioscience is a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Our solution, the INVO Procedure, is a disruptive new technology. The INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience. Our lead product, the INVOcell, is a patented medical device used in infertility treatment and is considered an Assisted Reproductive Technology (ART). The INVOcell is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development, as an alternative to traditional In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI). Our mission is to increase access to care and expand fertility treatment across the globe with a goal to lower the cost of care and increase availability of care.

IPO YEAR:

Sector:
Health Care
Industry:
Medical/Dental Instruments
ADRTSO:

MarketCap:
4612945.00
Beta:
2.237961837964474
52 Week High:
12.3
52 Week Low:
2.67
52 Week Change:
0.18729641693811083
Short Interest:

Short Date:

Shares Outstanding:
11734772
Dividend Rate:
0
Dividend Yield:
10.12%
ExDividend Date:

Latest EPS:

Latest EPS Date:
N/A
Float:
0
return on Equity:
-
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
0
Revenue:
N/A
Gross Profit:

Cash:

Debt:

Institution Percent:
42.95%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
-
Return on Assets:
-
Return on Capital:

Profit Margin:
-
Price to Sales:
-
Price To Book:
-
Short Ratio:
0.32
PE Ratio:
0
Employees:
10
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__INVO BioScience Inc. Common Stock [ INVO ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30